---
category: news
title: "Vivacitas Oncology and IAG Partner to Integrate Novel Imaging Markers in the Development of AR-67 in Recurrent Glioblastoma Patients"
excerpt: "WALNUT CREEK, CA and LONDON, UK / ACCESSWIRE / May 3, 2021 / Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a clinical stage biopharmaceutical company focused on tough to treat cancers, and Image Analysis Group (“IAG”),"
publishedDateTime: 2021-05-03T13:01:00Z
originalUrl: "https://apnews.com/press-release/accesswire/health-business-technology-001747bac29b867e435542563415196b"
webUrl: "https://apnews.com/press-release/accesswire/health-business-technology-001747bac29b867e435542563415196b"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "rZSAUyO/d9A5pJuz6gwHpPCbSkce8jFLr2JhNk51LOGs0BI4VtdZ6a/aABfEacF+OsJenmbXBPzXsg1RjwMJ+QMD6L14nI0d51JWZsd4bvmM+h0I+R+h8dNX1s9raXzMJHHGP4XLQ6rhDpO1ahjKbNwOW8g/Mv2YHvqvjJ219dtlZBcfbqF92MSgSJXjxLP+tp4aq+JvLuvc1XovcOCynZRso3yc4Gg5J6Qj6EEKnz7a4xNEPFsTG808Dk3TyJBpoPxSjTv4cdffRyK+2ZnWnyTKNC734tQHWy6CL/L/RpThR5XmbaBnt7I7AyAlpNJU5c4vNDpRde/ndde5WMaGIw5O0cyk/BjwIW33gkMjfcc=;ODf130AvZ6T3w0LKZf6Blg=="
---

